Divi's Laboratories Limited (DIVISLAB) Q2 FY27 Financial Results: PAT ₹902 Cr & Revenue ₹3,144 Cr

Divi's Laboratories reported consolidated revenue of ₹3,144 crores and profit after tax of ₹902 crores for Q1 FY27, up 10% in constant currency YoY. Export revenue contributed 90% of standalone sales, with custom synthesis driving 60% of revenue. The company highlighted margin pressure from raw material inflation but implemented price increases to offset it, projecting double-digit full-year growth despite quarterly lumpiness. Capex on three major projects reached 70% completion with an estimated ₹2,000 crores investment. Unit utilization stands at 80-85%, and inventory was increased by 3 months to ensure supply continuity amid geopolitical risks.